These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 10640312

  • 1. Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
    Oerther S, Ahlenius S.
    J Pharmacol Exp Ther; 2000 Feb; 292(2):731-6. PubMed ID: 10640312
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.
    Tarazi FI, Zhang K, Baldessarini RJ.
    J Pharmacol Exp Ther; 2001 May; 297(2):711-7. PubMed ID: 11303062
    [Abstract] [Full Text] [Related]

  • 3. Anti-cataleptic effects of clozapine, but not olanzapine and quetiapine, on SCH 23390- or raclopride-induced catalepsy in rats.
    Ahlqvist J, Isacson R, Wahlestedt C, Salmi P.
    Eur Neuropsychopharmacol; 2003 May; 13(3):177-82. PubMed ID: 12729943
    [Abstract] [Full Text] [Related]

  • 4. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
    Ninan I, Kulkarni SK.
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
    [Abstract] [Full Text] [Related]

  • 5. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
    Atmaca M, Kuloglu M, Tezcan E, Ustundag B.
    J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
    [Abstract] [Full Text] [Related]

  • 6. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J, Hussain T, Agid O, Verhoeff NP, Wilson AA, Houle S, Remington G, Zipursky RB, Kapur S.
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.
    Deveney AM, Waddington JL.
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):40-9. PubMed ID: 8935799
    [Abstract] [Full Text] [Related]

  • 8. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
    Ichikawa J, Li Z, Dai J, Meltzer HY.
    Brain Res; 2002 Nov 29; 956(2):349-57. PubMed ID: 12445705
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.
    Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA.
    J Pharmacol Exp Ther; 2000 Apr 29; 293(1):8-14. PubMed ID: 10734147
    [Abstract] [Full Text] [Related]

  • 10. Effects of antipsychotic drugs on operant responding after acute and repeated administration.
    Varvel SA, Vann RE, Wise LE, Philibin SD, Porter JH.
    Psychopharmacology (Berl); 2002 Mar 29; 160(2):182-91. PubMed ID: 11875636
    [Abstract] [Full Text] [Related]

  • 11. The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats.
    Ahnaou A, Megens AA, Drinkenburg WH.
    Neuropsychobiology; 2003 Mar 29; 48(1):47-54. PubMed ID: 12886041
    [Abstract] [Full Text] [Related]

  • 12. Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions.
    Tarazi FI, Zhang K, Baldessarini RJ.
    Psychopharmacology (Berl); 2002 May 29; 161(3):263-70. PubMed ID: 12021829
    [Abstract] [Full Text] [Related]

  • 13. alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
    Kalkman HO, Loetscher E.
    Eur J Pharmacol; 2003 Feb 21; 462(1-3):33-40. PubMed ID: 12591093
    [Abstract] [Full Text] [Related]

  • 14. A model of anticholinergic activity of atypical antipsychotic medications.
    Chew ML, Mulsant BH, Pollock BG, Lehman ME, Greenspan A, Kirshner MA, Bies RR, Kapur S, Gharabawi G.
    Schizophr Res; 2006 Dec 21; 88(1-3):63-72. PubMed ID: 16928430
    [Abstract] [Full Text] [Related]

  • 15. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
    Ichikawa J, Ishii H, Bonaccorso S, Fowler WL, O'Laughlin IA, Meltzer HY.
    J Neurochem; 2001 Mar 21; 76(5):1521-31. PubMed ID: 11238736
    [Abstract] [Full Text] [Related]

  • 16. The effects of novel antipsychotics on glucose and lipid levels.
    Wirshing DA, Boyd JA, Meng LR, Ballon JS, Marder SR, Wirshing WC.
    J Clin Psychiatry; 2002 Oct 21; 63(10):856-65. PubMed ID: 12416594
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.